General information about company

Scrip code*543213
NSE Symbol*ROSSARI
MSEI Symbol*NOTLISTED
ISIN*INE02A801020
Name of companyROSSARI BIOTECH LIMITED
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2026
Date of end of financial year31-03-2027
Date of board meeting when results were approved17-10-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange09-10-2026
Description of presentation currencyINR
Level of roundingMillions
Reporting TypeQuarterly
Reporting QuarterSecond quarter
Nature of report standalone or consolidatedConsolidated
Whether results are audited or unaudited for the quarter endedUnaudited
Whether results are audited or unaudited for the Year to date for current period ended/year endedUnaudited
Segment ReportingSingle segment
Description of single segmentManufacturing of Specialty Chemicals for Textile, Home and Personal Care, Performance Chemicals and Animal Health and Nutrition industries
Start date and time of board meeting17-10-2026 17:48
End date and time of board meeting17-10-2026 18:30
Whether cash flow statement is applicable on companyYes
Type of cash flow statementCash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualificationNot applicable



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-07-202601-04-2026
Date of end of reporting period30-09-202630-09-2026
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations6975.613947.6
Other income5.9937.86
Total income6981.5913985.46
2Expenses
(a)Cost of materials consumed4756.439903.21
(b)Purchases of stock-in-trade177.86324.49
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade-161.21-546.37
(d)Employee benefit expense 436.16876.6
(e)Finance costs86.77196.54
(f)Depreciation, depletion and amortisation expense300.96557.11
(g)Other Expenses
1Other Expenses896.621713.73
Total other expenses896.621713.73
Total expenses6493.5913025.31
3Total profit before exceptional items and tax488960.15
4Exceptional items 00
5Total profit before tax488960.15
6Tax expense
7Current tax123.1284.32
8Deferred tax-19.48-54.93
9Total tax expenses103.62229.39
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations384.38730.76
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method4.699.26
16Total profit (loss) for period389.07740.02
17Other comprehensive income net of taxes6.5310.04
18Total Comprehensive Income for the period395.6750.06
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent389.07740.02
Total profit or loss, attributable to non-controlling interests
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent395.6750.06
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21Details of equity share capital
Paid-up equity share capital110.79110.79
Face value of equity share capital22
22Reserves excluding revaluation reserve
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations7.0213.36
Diluted earnings (loss) per share from continuing operations7.0213.36
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations7.0213.36
Diluted earnings (loss) per share from continuing and discontinued operations7.0213.36
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Statement of Asset and Liabilities

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2026
Date of end of reporting period30-09-2026
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedConsolidated
Assets
1 Non-current assets
Property, plant and equipment5107.34
Capital work-in-progress1562.1
Investment property0
Goodwill1187.11
Other intangible assets1874.8
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method279.06
Non-current financial assets
Non-current investments0.11
Trade receivables, non-current
Loans, non-current0
Other non-current financial assets
1Other Financial Assets97.06
2
3
4
5
Details of other non-current financial assets
Total of other non-current financial assets97.06
Total non-current financial assets97.17
Deferred tax assets (net)172.43
Other non-current assets
1Income tax Assets(Net)118.86
2Other non-current assets189.02
3
4
5
Details of other non-current assets
Total of other non-current assets307.88
Total non-current assets10587.89
2Current assets
Inventories4439.85
Current financial asset
Current investments300.22
Trade receivables, current5536.69
Cash and cash equivalents844.44
Bank balance other than cash and cash equivalents264.3
Loans, current9.82
Other current financial assets
1Other current financial assets64.02
2
3
4
5
Details of other current financial assets
Total of Other current financial assets64.02
Total current financial assets7019.49
Current tax assets (net)
Other current assets
1Other current assets1547.4
2
3
4
5
Details of other current assets
Total of other current assets1547.4
Total current assets13006.74
3Non-current assets classified as held for sale
4Regulatory deferral account debit balances and related deferred tax Assets
Total assets23594.63
Equity and liabilities
1Equity
Equity attributable to owners of parent
Equity share capital110.79
Other equity13965.18
Total equity attributable to owners of parent14075.97
Non controlling interest
Total equity14075.97
2Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current820.81
Trade Payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1Lease Liabilities171.71
2
3
4
5
Details of other non-current financial liabilities
Total of other non-current financial liabilities171.71
Total non-current financial liabilities992.52
Provisions, non-current95.05
Deferred tax liabilities (net)402.11
Deferred government grants, Non-current
Other non-current liabilities
1
2
3
4
5
Details of other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities1489.68
Current liabilities
Current financial liabilities
Borrowings, current2796.91
Trade Payables, current
(A) Total outstanding dues of micro enterprises and small enterprises303.35
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises3132.5
Total Trade payable3435.85
Other current financial liabilities
1Lease Liabilities91.13
2Other financial liabilities1238.52
3
4
5
Details of other current financial liabilities
Total of other current financial liabilities1329.65
Total current financial liabilities7562.41
Other current liabilities
1Other current liabilities260.47
2
3
4
5
Details of other current liabilities
Total of other current liabilities260.47
Provisions, current87.65
Current tax liabilities (Net)118.45
Deferred government grants, Current
Total current liabilities8028.98
3Liabilities directly associated with assets in disposal group classified as held for sale
4Regulatory deferral account credit balances and related deferred tax liability
Total liabilities9518.66
Total equity and liabilities23594.63
Disclosure of notes on assets and liabilities

Other Comprehensive Income

Date of start of reporting period01-07-202601-04-2026
Date of end of reporting period30-09-202630-09-2026
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
1 Remeasurements of the defined benefit plans0.490.99
Total Amount of items that will not be reclassified to profit and loss0.490.99
2Income tax relating to items that will not be reclassified to profit or loss 0.120.25
3Amount of items that will be reclassified to profit and loss
1Exchange difference on translation of foreign operations8.2312.43
Total Amount of items that will be reclassified to profit and loss8.2312.43
4Income tax relating to items that will be reclassified to profit or loss 2.073.13
5Total Other comprehensive income6.5310.04


Cash flow statement, indirect

ParticularsHalf Year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2026
Date of end of reporting period30-09-2026
Whether results are audited or unauditedUnaudited
Nature of report standalone or consolidatedConsolidated
Part IBlue color marked fields are non-mandatory.
1Statement of cash flows
Cash flows from used in operating activities
Profit before tax960.15
2Adjustments for reconcile profit (loss)
Adjustments for finance costs199.9
Adjustments for decrease (increase) in inventories-394.4
Adjustments for decrease (increase) in trade receivables, current-158.34
Adjustments for decrease (increase) in trade receivables, non-current0
Adjustments for decrease (increase) in other current assets0
Adjustments for decrease (increase) in other non-current assets0
Adjustments for other financial assets, non-current0
Adjustments for other financial assets, current0
Adjustments for other bank balances0
Adjustments for increase (decrease) in trade payables, current391.45
Adjustments for increase (decrease) in trade payables, non-current0
Adjustments for increase (decrease) in other current liabilities-0.09
Adjustments for increase (decrease) in other non-current liabilities0
Adjustments for depreciation and amortisation expense557.11
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss0
Adjustments for provisions, current27.99
Adjustments for provisions, non-current0
Adjustments for other financial liabilities, current0
Adjustments for other financial liabilities, non-current0
Adjustments for unrealised foreign exchange losses gains4.28
Adjustments for dividend income0
Adjustments for interest income8.82
Adjustments for share-based payments14.83
Adjustments for fair value losses (gains)-3.5
Adjustments for undistributed profits of associates0
Other adjustments for which cash effects are investing or financing cash flow-21.89
Other adjustments to reconcile profit (loss)0
Other adjustments for non-cash items0.49
Share of profit and loss from partnership firm or association of persons or limited liability partnerships0
Total adjustments for reconcile profit (loss)609.01
Net cash flows from (used in) operations1569.16
Dividends received0
Interest paid0
Interest received0
Income taxes paid (refund)254.93
Other inflows (outflows) of cash0
Net cash flows from (used in) operating activities1314.23
3Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses0
Cash flows used in obtaining control of subsidiaries or other businesses0
Other cash receipts from sales of equity or debt instruments of other entities56.28
Other cash payments to acquire equity or debt instruments of other entities0
Other cash receipts from sales of interests in joint ventures0
Other cash payments to acquire interests in joint ventures0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships0
Proceeds from sales of property, plant and equipment103.54
Purchase of property, plant and equipment573.83
Proceeds from sales of investment property0
Purchase of investment property0
Proceeds from sales of intangible assets0
Purchase of intangible assets0
Proceeds from sales of intangible assets under development0
Purchase of intangible assets under development0
Proceeds from sales of goodwill0
Purchase of goodwill0
Proceeds from biological assets other than bearer plants0
Purchase of biological assets other than bearer plants0
Proceeds from government grants0
Proceeds from sales of other long-term assets0
Purchase of other long-term assets0
Cash advances and loans made to other parties0
Cash receipts from repayment of advances and loans made to other parties0
Cash payments for future contracts, forward contracts, option contracts and swap contracts0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts0
Dividends received0
Interest received8.38
Income taxes paid (refund)0
Other inflows (outflows) of cash-89.7
Net cash flows from (used in) investing activities-495.33
4Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries0
Payments from changes in ownership interests in subsidiaries0
Proceeds from issuing shares4.57
Proceeds from issuing other equity instruments0
Payments to acquire or redeem entity's shares0
Payments of other equity instruments0
Proceeds from exercise of stock options0
Proceeds from issuing debentures notes bonds etc0
Proceeds from borrowings29.59
Repayments of borrowings491.73
Payments of lease liabilities51.91
Dividends paid27.7
Interest paid186.61
Income taxes paid (refund)0
Other inflows (outflows) of cash0
Net cash flows from (used in) financing activities-723.79
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes95.11
5Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents-3.74
Net increase (decrease) in cash and cash equivalents91.37
Cash and cash equivalents cash flow statement at beginning of period753.07
Cash and cash equivalents cash flow statement at end of period844.44